CIK 0000886744
- Large accelerated filer
GERON CORP
Sign in to watch- Ticker
- GERN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 752287752
- Phone
- +1 650-473-7700
- Business address
- 919 EAST HILLSDALE BOULEVARD, SUITE 250, FOSTER CITY, CA, 94404
- Former names
- GERON CORPORATION
- Open-market buys, last 90 days
- $62,105
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$62,105. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-11 | O'Farrell Elizabeth G. Director | Grant or award · Stock Option (right to buy) | +83,000 | 83,000 | ||
| 2021-05-11 | Bir Dawn Carter Director | Grant or award · Stock Option (right to buy) | +83,000 | 83,000 | ||
| 2021-05-11 | EASTHAM KARIN Director | Grant or award · Stock Option (right to buy) | +83,000 | 83,000 | ||
| 2021-05-11 | Spiegel Robert J. Director | Grant or award · Stock Option (right to buy) | +83,000 | 83,000 | ||
| 2021-05-11 | Molineaux Susan Director | Grant or award · Stock Option (right to buy) | +83,000 | 83,000 | ||
| 2021-05-11 | LAWLIS V BRYAN Director | Grant or award · Stock Option (right to buy) | +83,000 | 83,000 | ||
| 2021-03-31 | Spiegel Robert J. Director | Grant or award | +4,549 | 119,497 | ||
| 2021-02-02 | ROSENFIELD STEPHEN EVP, Chief Legal Off & Sec | Grant or award · Employee Stock Option (Right to buy) | +300,000 | 300,000 | ||
| 2021-02-02 | Bloom Olivia Kyusuk EVP, Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2021-02-02 | BEHRS MELISSA KELLY EVP, Chief Business Officer | Grant or award · Employee Stock Option (Right to buy) | +300,000 | 300,000 | ||
| 2021-02-02 | SCARLETT JOHN A Chairman, President and CEO | Grant or award · Employee Stock Option (Right to buy) | +600,000 | 600,000 | ||
| 2021-02-02 | Kapur Anil EVP, Corp Strategy & CCO | Grant or award · Employee Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2021-02-02 | GRETHLEIN ANDREW J EVP, Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2021-02-02 | Rizo Aleksandra EVP, Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2020-12-31 | Spiegel Robert J. Director | Grant or award | +4,520 | 114,948 | ||
| 2020-09-30 | Spiegel Robert J. Director | Grant or award | +4,130 | 110,428 | ||
| 2020-08-21 | O'Farrell Elizabeth G. Director | Purchase | +17,441 | $1.73 | $30K | 19,641 |
| 2020-06-30 | Spiegel Robert J. Director | Grant or award | +3,297 | 106,298 | ||
| 2020-06-05 | Spiegel Robert J. Director | Grant or award · Stock Option (right to buy) | +83,000 | 83,000 | ||
| 2020-06-05 | O'Farrell Elizabeth G. Director | Grant or award · Stock Option (right to buy) | +83,000 | 83,000 |
Page 10 of 15 · 291 trades